N-1,10-phenanthrolin-5-ylacetamide

N-1,10-phenanthrolin-5-ylacetamide Uses, Dosage, Side Effects, Food Interaction and all others data.

Trade Name N-1,10-phenanthrolin-5-ylacetamide
Generic N-1,10-phenanthrolin-5-ylacetamide
Type
Formula C14H11N3O
Weight Average: 237.2566
Monoisotopic: 237.090211989
Groups Experimental
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
N-1,10-phenanthrolin-5-ylacetamide
N-1,10-phenanthrolin-5-ylacetamide

Innovators Monograph

You find simplified version here N-1,10-phenanthrolin-5-ylacetamide



https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=18719622
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=99444911
https://www.chemspider.com/Chemical-Structure.18970157.html
https://zinc.docking.org/substances/ZINC000053683165
https://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/PXX
*** Taking medicines without doctor's advice can cause long-term problems.
Download Bissoy app from Play Store to get doctor's consultation over video call
Dr. Tanvir Rahman Shah

Dr. Tanvir Rahman

Psychiatrist

 Call Doctor
Dr. Zahidul Islam

Dr. Zahidul Islam

Child Specialist

 Call Doctor
Dr. Md. Mostofa Alam Bony

Dr. Md. Mostofa Alam Bony

Medicine Specialist

 Call Doctor
Dr. Khondoker Monirul Alam Russel

Dr. Khondoker Monirul Alam

Gastroenterologist

 Call Doctor
Dr. Sultana Ashrafi Ahmed

Dr. Sultana Ashrafi Ahmed

Kidney Specialist

Call Doctor
Dr. Md. Najmul Karim

Dr. Md. Najmul Karim

Hematologist

 Call Doctor
Dr. Redwana Hossain

Dr. Redwana Hossain

Psychiatrist

 Call Doctor
Dr. Md Waliur Rahman

Dr. Md Waliur Rahman

Child Specialist

 Call Doctor
Share

Related Content

6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE
4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol
2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol
3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile
(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE
3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile
3-{3-[(DIMETHYLAMINO)METHYL]-1H-INDOL-7-YL}PROPAN-1-OL
(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol
2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid
N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine
Electrocardiogram
Antibody Serology Tests
Complement
BRCA Genetic Test
Breast biopsy - ultrasound
Electromyography (EMG) and Nerve Conduction Studies
MPV Blood Test
Glomerular filtration rate
COVID-19 symptoms
X-ray
Neuronal ceroid lipofuscinosis type 2
Eye Pain
Refractory Non-Hodgkin's lymphoma
nose
Contact
Major Bleeding
Hematologic
Locally advanced Gastrointestinal stromal tumor
Symptomatic Botulism caused by Clostridium botulinum serotype B
Hypoactive Sexual Desire Disorder (HSDD)